hyaluronoglucosaminidase has been researched along with Bare Lymphocyte Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carne, E; El-Shanawany, T; Jolles, S; Pickersgill, T; Ponsford, M; Williams, P | 1 |
| Vellard, M | 1 |
1 review(s) available for hyaluronoglucosaminidase and Bare Lymphocyte Syndrome
| Article | Year |
|---|---|
The enzyme as drug: application of enzymes as pharmaceuticals.
Topics: Adenosine Deaminase; Administration, Inhalation; Administration, Oral; Animals; Chondroitinases and Chondroitin Lyases; Communicable Diseases; Enzyme Therapy; Humans; Hyaluronoglucosaminidase; Neoplasms; Peptide Hydrolases; Severe Combined Immunodeficiency | 2003 |
1 other study(ies) available for hyaluronoglucosaminidase and Bare Lymphocyte Syndrome
| Article | Year |
|---|---|
Five years of self-administered hyaluronidase facilitated subcutaneous immunoglobulin (fSCIg) home therapy in a patient with primary immunodeficiency.
Topics: Adult; Drug Administration Schedule; Female; Humans; Hyaluronoglucosaminidase; Immunoglobulins; Infusions, Subcutaneous; Self Administration; Severe Combined Immunodeficiency; Thigh; Time Factors; Treatment Outcome | 2016 |